Homoeopathy Syllabus > MD Syllabus > MATERIA MEDICA INCLUDING APPLIED ASPECTS

New MD(Hom) Syllabus

Revised and updated by Vinayaka Mission Deemed University and approved by CCH and Included in the 2nd Schedule

MATERIA MEDICA INCLUDING APPLIED ASPECTS

INTRODUCTION

The two-part syllabus has been designed with the objective of delivering to the candidate the entire experience of basic and applied aspects of Homoeopathic health-care applicable to the discipline of Materia Medica. The representation reproduced below will clarify the basic philosophical and conceptual position to be taken to appreciate the syllabus.

MD-Part.I takes the candidate on the journey from Man in health a Man in disease. The ground that he has covered earlier in the undergraduate course is gone over again but from a very different clinical perspective. The integrated approach a clinician needs to adopt will underlie the exposure to these subjects. This will be facilitated since the candidate is simultaneously doing his resident training and is seeing the phenomena of health being transformed into disease in his clinical studies. Having thus re-visited the basic sciences, the candidate is now prepared to undertake the journey deeper into the healing science and art attempting to come into more intimate contact with the principles that Hahnemann identifies as critical for the success of the ‘Operation Cure. Hence we should be very clear about the philosophical and conceptual basis of the syllabus and the ground that we need to cover. We should evolve matching methods and techniques that will experientially deliver to the candidate the entire experience of ‘Healing’ in its Hahnemannian sense.

We must also remember that unlike in Modern medicine, there can be no standardization of Homoeopathic management of different clinical conditions. All the same, we should be able to define a common approach to the understanding of the condition and it is expected that with the passage of time and accurate documentation (which will follow the establishment of Postgraduate education), an approach will evolve. Till then we will be required to integrate our general understanding of the clinical and pathological phenomena of disease with our knowledge of Materia Medica and apply philosophical concepts to evolve the approach. References to literature are thus, at best, only general and constitute preliminary readings for take off. The role of the guide and teacher will be paramount in evolving guidelines.

BASIC CONCEPTS
Part — I has already dealt with the following areas: -
(1) Structural basis of health and disease (Anatomical organization of man and its degeneration into structural pathology)
(2) Functional basis of health and disease (Physiological organization of man and its degeneration into patho-physiology)
(3) Psychological basis of health and disease and the abnormal psychological processes which initiate abnormal mental and psycho-physiological functioning
(4) The Concept of Man that the clinician needs in order to function in the clinical setting
(5) The scientific and full use of the extended senses of Clinical Investigations to unravel the hidden, often nascent stage in the evolution of the disease
(6) Final integration of all of the above with the basic tenets of Homoeopathic Philosophy.
(7) Integrating all the above phenomena to conceptualize the study of Homoeopathic Materia Medica and its application from health to disease.

Part—II is now poised to take the candidate to understand the application of the above knowledge in terms of the following:
(1) Evolving an approach to the Definition of the Clinical Problem
(2) Understanding the crucial role of documentation in the scientific understanding of the clinical state and artificial disease phenomena
(3) Possessing a sound understanding of the Bio-Psycho-Social concept of etiopathogenesis and evolution of the disease phenomena to integrate with the study of Materia Medica
(4) Evolving clinico-pathological correlations to grasp the essence of the disease phenomena and integrate in terms of the structural, functional and formal correlations of disease and Materia Medica
(5) Understanding different eras & concepts of the earlier times & their influence on the construction of Materia Medica.
(6) Learning the basics of Classification of Disease and integrating these principles with the Hahnemannian approach to understand the depth and extent of Homoeopathic remedies
(7) Integrating all of the above in the erection and appropriate processing of the Hahnemannian Totality
(8) Application in terms of evolving suitable Materia Medica portraits and utilization of the drug force in a correct manner to complete the ‘Operation Cure’ as per Hahnemann’s directions in Aphorism 2.
(9) Scope & Limitation of the current state of knowledge of Homoeopathic Materia Medica with the demands of Clinical Practice and Education
(10) Finally, the need for the physician to take on the role of the ‘Unprejudiced Observer’ (Aphorism 6) while carrying out all of the above actions.

Materia Medica study at the postgraduate level will require a definite methodology. The steps needs clear definition. The diagrams below would give an overview of the place of Materia Medica in our plan of study and the vast area of Materia Medica that we are covering in the course. It should be clear that the purpose of the study is to equip the physician with a Philosophy and a Method and not cram him with facts that are possible to refer to the books while at the bedside. Hence unlike conventional syllabus at the undergraduate level, this Syllabus does not carry the mandatory medicinal list. At the same time, groups of remedies, which are commonly used, have been mentioned to be taken up as illustrations for understanding and mastering the philosophy, the methodology and the techniques of Materia Medica.

The presentation that follows is based on the pattern of the PG notification. Should there be any confusion, reference to the Fig 3 should be resorted to.

(I) BASIC MATERIA MEDICA

(1) Science & Philosophy of Materia Medica:
Concept, understanding & philosophy of Materia Medica & its evolution
This is based on a clear grasp of the following concepts and principles:
a. Concept of Man Universe
b. Principles of Logic-Analysis and Synthesis
c. Law of Similars
d. Concept of Natural and Artificial Disease
e. Principle of Evolution, Causation and Concomitance
f. Concepts of Structure, Form and Function
g. Principles of classification of Data and categorization into Generals and particulars
h. Concept of Totality
i. Concept of Relationships
Most of these concepts would have been covered in Part I of the course but would need a reiteration while introducing the study of Materia Medica

(2)Source of Materia Medica, Drug proving and Collection of symptoms:
a. Source of Materia Medica:
Understanding the concept of the different sources of Materia Medica, their scope & limitations and their utilisation & importance in building up of totalities of drugs. Sources —Toxicological, Drug Proving, Clinical, Chemical, Physical, Biological properties.
b. Drug proving Method, Recording, Reporting as laid down by Hahnnemann and developed and modified by the later workers with the advantages and limitations of their work.
c. Collection and Classification of Symptoms

Classifying the symptoms based on general principles of analysis and synthesis

a. Classification & giving a meaning to data collected from proving & different sources.
Systematic application of these concepts to the study of a well-proved polychrests in the Homoeopathic Materia Medica requires us to examine our source books in a critical manner

The following method is found to be advantageous if observed meticulously:
(i) Each symptom is broken up and re-arranged under the Standard Headings as under:
(A) Cause: This is identified and studied in great detail to bring out the Characteristic Expression (effects) by establishing horizontal correlates in a clear manner;
(B) Sphere & Scope of Effects: Sensations & Complaints in General, Mental State, Regional Effects: Tissues, Organs & Pathology;
(C) Circumstances of Aggravation & Amelioration: General as well as Particular (Regional) with special emphasis on those which run counter to the general modalities and thus serve us well as important differential modalities;
(D) Characteristic particulars: Along with the modalities and strict concomitants
(A) Circumstances of Aggravation & Amelioration: General as well as Particular (Regional) with special emphasis on those which run counter to the general modalities and thus serve us well as important differential modalities;
(D) Characteristic particulars: Along with the modalities and strict concomitants

(ii) The data in the source books, which is normally arranged as per Locations is re-arranged in 4 Columns — Psora, Sycosis, Tubercular, and Syphilis.

(iii) Psora furnishes us not only with the fundamental base for the Chronic Diseases, but it also determines its Characteristic Expression by virtue of the Sensitivity it governs the Concomitants it gives rise to. It is dominant in the functional early phase of any illness and tends to fade out progressively with the evolution and march of the disease through the next phases of Sycosis, Tubercle and Syphilis (Terminal Phase). These next three phases, in spite of their predilection to the formation of structural alterations of a type specific to the particular Miasm, have also an early functional phase, which has to be identified clearly in the pathogenesis of every drug if we are to cure effectively. Characteristic expressions of these early functional phases can also be studied in the pathogenesis of every drug and these furnish us with important guidelines to effective Homoeopathic prescribing for the chronic case.
Causative Factors can be identified in all these 4 Miasmatic Expressions. The effects produced by the Causative Factors(s) are not necessarily limited to the Miasm with which we identify it; these effects can spill over into other Miasms; these effects can be classified as (i) Common to the Miasmatic Group and (ii) Characteristic to the Drug; the latter Characteristic Expressions are of special interest in the evolution of the Portrait of Disease in the true Hahnemannian sense.
These evolutionary aspects of the ‘Artificial Drug-Disease’ can be studied in an effective manner only when we examine this re-classified (as per (i) & (ii) above) data in the light of our present knowledge of clinical pathology of diseases. When we do this, we are able to establish rational horizontal cross-connections between the data arranged and classified in the vertical columns representing Psora, Sycosis, Tubercular and Syphilis.
A characteristic and distinctive pattern emerges in our mind, which is derived from the data in the source books of the Homoeopathic Materia Medica. This is the Hahnemannian Totality, which we should endeavor to create and store in our mind. It should guide us to examine the Source Books in greater detail in search of specific characteristics when we are confronted with a patient who reminds us in a general way of the portrait of the disease of the drug in question. No attempt should be made to remember or memorize these specific symptoms in the Homoeopathic Materia Medica, which is vast and proves to be a maze to the uninitiated.
Hahnemann’s Concept of the ‘Portrait of Disease’ (Aphorism 6, Organon of Medicine) and its miasmatic evolution from the symptoms recorded in the Homoeopathic Materia Medica. Miasmatic evolution of disease follows the following pattern:
Psora - Sycosis - Tubercular - Syphilis

c. Types of Materia Medica
The various types of Materia Medicas available viz. Drug provings, Key notes, Commentaries, Compendiums, Synopses etc.-their evolution and their place in the current study needs to be highlighted.

(3) Study of Materia Medica: Different Approaches as detailed in the following Paper: Kasad, K. N.: Post-Graduate Teaching in Homoeopathy:
Homoeopathic Materia Medica
(i) Appendix B-2 of the “Principles and Practice of Homoeopathy: Part I- Homoeopathic Philosophy and Repertorization”
by M. L. Dhawale (i) Transactions of the international Homoeopathic
League, Triennial Congress, New Delhi, 1967.
(A) Concept of Drug Picture:
Kent, Boger, Pulford, Harvey Farrington, Margaret Tyler, Borland.
(B) Repertorial Techniques for the evolution of the Drug Pictures from Symptoms
Note:
(1) The Approach to the Study of these Drugs should effectively demonstrate the application of the Principles laid down in the preceding Sections.
(2) Drugs should be studied in Groups, stressing the Common as well as the differential features of the individual drugs included in the Group.
(3) Study should lay stress on the Method and Approach and not so much on Factual Knowledge, access to which, is really provided by the Repertories. Examination, thus, would not be primarily a Test of Memory but of the capacity to organize and deal effectively with the mass of data presented by the Homoeopathic Materia Medica.
(4) Drugs in Category I: These are to be studied systematically to bring out the ‘Portrait of the Disease’ under standard Headings (Method II, P. 7-8)with minimal emphasis on Characteristic particulars. Acute as well as Chronic Prescribing Totalities with their Relationships are to be stressed. Full Questions on the Group or individual members of the Group may be asked in the Paper.
(5) Drugs in Category II: These are to be studied in a more restrictive manner, stressing their Prescribing Totalities in the spheres In which the drug is commonly employed. Here stress is more often on the Characteristic. Particulars; important Generals, where they are clearly established, however, are not to be neglected. Standard I-leadings under Method I (P.7) should be followed here. None of these drugs shall form the topic for a full question in the Paper.

CATEGORY.I	CATEGORY.II
I. Congestive Group
Aco.n Bell. Stram, (Comp. Verat, .Alb.) Hyosc. Verat. vir. Ferrum met, Ferrum phos.	Glonoine
2. Injuries, Rheumatic States, Neuralgias
Arn. mont Bell. Rhustox. (Comp. other Rhus) Bry. alb. Puls.n. (Comp. KaIi sulph and Cyclamen) Phytolacca Cimicifuga Eup.perf (Comp. Eup. pur.) Coffea	Rhododendron Kalmia Ledum Hyper. Symph. Bellis p. Guaiacum Ruta g. Urtica urens Stront. carb. Dulcamara Sanicula Sanguinaria Spigelia Ranunculus b& s Plantago m
3.Spasmodic & Irritable Group
Cham. Cina Coloc. Staph. Nux.vom. Cup. met. (Comp. Verat. aib) Cup. ars. Secale cor.	Cicuta V. Dioscorea Viburnum Caulophyllum Lyssin
4. Urinary Drugs
Canth. (Comp. Merc.cor) Apis mel Capsicum Berberis v. Sarsaparilla	Cannabis indica & sat.
5.Digestive Drugs
Verat.alb.(Comp.Camph., Cup. SecaleCor.& Carb.veg.) Anacardium	Aethusa Ipecac. Rheum Chelid. m. Leptandra Cadmium met. & Sulph.
6. Rectal Drugs
Aloes Aesculus Hammamelis Ratanhia Podophyllum Collinsonia
7. Respiratory Drugs Upper Respiratory Tract
Allium cepa Arum t. Euphrasia Sabadilla Sambucus Sticta Pulmonalis
Spasmodic Cough
Drosera Coccuscact Corallium rubrum, Pertussin
Loose Cough
Rumex Senega Hydrastis Lobelia Stannum iod. Stannum Met	Collapse Antimony crud. & tart. Ipecac Ammonium carb(Comp.Ars.alb) Antimony ars.
8. Heart Drugs
Digitalis	Ars. lod. Strychnine Ars.& Phos. Cactus g. Laurocerasus Lycopus Lactrodectus m.
9. Debility Group
China Phos. ac Mur. ac	Chin. ars. Picric acid Selenium Uranium nitrate
10. Natrum Group
Natrum carb. Natrum mur. Natrum phos. Natrum suiph. Thuja	Natrum ars. Natrum iod. Natrum h. Borax
Sycotic Drugs
Medorrhinum
11. Kali Group
Kah carb. Kali bichrom. Kali mur. Kali Sulph. Causticum (Comp. phos.)	Kali ars. Kali brom. Kali.iod Chlor.
12. Calcarea Group
Calc. carb. Calc. ars. Calc. Phos. Calc. sil Calc. Flour. Calc. Sulplh. Calc. iod.
13. Baryta Group
Baryta carb. Baryta mur. Baryta iod.
14. Magnesia Group
Mag. Carb. Mag. Mur. Mag. Phos. Mag. SuIph
15. Alumina, Silica and Carbon Group
Alumina Silica Carb.A n Carb. veg. Graph. Petroleum Sanicula	Alumen
16. Phosphorus and Tuberculins
Phos. (Comp. Causticum) Tuberculinum bovinum Aviare Bacillinum
17. Mercury Group and Antisyphilitics
Mercurius sol. Mercurius cor. Merc. Cyan. Merc. Dul. Merc. iod. Fl. Merc.iod. R. Hep. Sul. Nitric acid Aurum met. Ars.Alb. Ars. iod. Fluoric acid Kali iod. Syphilinum	Merc. Sul. Cinnaberis Asafoetida Mezereum Aurum mur. Aurum mur. N. Ars. Sul.
18. Snake Venoms & Sepsis
Lachesis Crotalus h Naja Baptisia Pyrogen	Crotalus c. Cenchris Bothrops 1. Vipera Elaps Echinecia Carbolic acid Tarent. C. Anthraxinum Staphylococin B. Coli Diptherinum
19. Spider Venoms
Tarent h.	Tarent. C. Latrodectus m. Aranea d. Mygale Theridion
20. Argentum Group & Related Drugs
Arg. Nit. Arg. Met. Gelsemium S Sepia	Murex Lilium tig. Sabadilla Sabina
21. Hysterical Group
Ignatia Nux moschata Platina Lac. C.	Valeriana off. Croc. sat. Sumbul
22. Paralytic Group
Camphor Conium Helleborus Opium Plumbum Zincum	Agaricus Coca Cocculus Lathyrus sat. Manganum Tabacum
23. Halogen Groups & Related Drugs
Iodine	Chlorum Bromium Spongia Badiag a Thyroidinum
24. Miscellaneous
Cadmium phos. Cobaltum Radium brom Radium iod. X-Rays
25. Uterine Group
Sabina Bovista Trillium Caulophyllum Viburnum Thlaspi bursa pastoris
26. Lycopodium (Comp. Berb. v. and Chelid.)
27. Sulphur	Sulphur iod.
28. Psorinum
29. Kreosote

(4) Sources of Drug Family or Group Characteristics and drug relationship:

Study of Animal, Mineral, Plant group in general. Deeper knowledge’s about individual source and drug properties not required accept very prominent. Family & group Symptoms of prominent classified group in different kingdom should be focussed, more focussing on frequently coming group characteristics.
1. Physiologic, Pharmacologic & Toxicologic Role: Importance and Derivations in respect of Sphere and Scope in the Pathogenesy.
2. Concept of the Group: Its Identification & Differentiation.
3. Members’ of the Group’: Identification— Specific General Expression.

(A) ANIMAL KINGDOM
Mammalia MOSCHUS, Castoreum,Oleum animale, Hippomanes,
Castor equi, Lac vaccinum, La defloratum, Lac caninum, Koumyss ,
Vertabrata
Fel tauri, Fel vulpi,Pulmo vulpis
Ophidia LACHESIS, CROTALUS,Bothrops, Agkistrodon, Elaps, Naja, Vipera
- Pisces oleum jecorisi aselli.
Batrachia Bufo rana

Mollusca SEPIAE SUCCUS, Murex.
Radiata Ccorallium rubrum, SPONGIA, Medusa,

Hemiptera coccus cacti, amex.
Hymenoptera APIS MELLIFICA, Vespa, Formica.

Artriculata
Coleoptera CANTHARIS.
Orthoptera Blatta
Arachnida Tarentula, Mygale,Theridion, Aranea.

(B) VEGETABLE KINGDOM
• Apocynaceae
• Loganiaceae
• Araceae
• Anacardiaceae
• Compositae
• Melanthaceae
• Menispermaceae
• Papaveraceae
• Cucurbitaceae
• Coniferae
• Euphorbiaceae
• Ranunculaceae
• Rubiaceae
• Scrophulariaceae
• Solanaceae
• Umbelliferae

(C) CHEMICAL APPROACH TO THE STUDY OF HOMOEOPATHIC MATERIA
1. General Validity: Relationship to Pathogenesy.
2. Anion & Cation Groupings: Relationship to the Periodic table & Reflections in the Pathogenesy.
3. Physiologic, Pharmacologic & Toxicologic Rote: Importance and Derivations in respect of Sphere and Scope in the Pathogenesy.
4. Concept of the ‘Group’: Its Identification & Differentiate
5. Members’ of the Groups: Identification — Specific General Expression.
6. ‘Salts’ in the ‘Members’: Specific Expression: individuality
7. Relationship of Pathogenesy of Drugs Thom ft Plant and Animal Kingdom to the Chemical Constituents.
8. Anion Groups: They are derivations from the Pathogenesy of the Element and its impact on the Pathogenesy of the Cation.

(b) Acids and Halogens: General Introduction
i. Acids: General Properties
ii. Sulphuric, Sulphurous
iii. Nitric & Nitrates; Hepar sulph.
iv. Muriatic & Phosphoric; China
v . Picric & Picrates
vi. Acetic & Acetates
vii. Chromic & Chromates
viii. Formic & Formaldehyde

(a) Halogens: general Properties
i.Fluoric Acid & Fluorides
ii.Chlorides & Chlorates
iii.Bromine & Bromides
iv.Iodine & lodides

(b) Sulphur, Sulphides, Sulphates
i. Sulphur iodide
ii. Psorinum
iii. Selenium
iv. Sanicula

(d) Arsenic and Arsenates
i. Arsenious Iodide
ii. Antimony

(e) Silica and Silicates
i. Alumina

9. Alkali Group; General Features
i. Lithium
ii. Natrums
iii. Kali.s

10. Alkaline Earths : General Features
i. Beryllium
ii. Magnesium
iii. Calcarea
iv. Lycopodium
v. Strontium
vi. Baryta

11.Radio-active Group: General Features
i. Radium
ii. Uranium Nitrate
iii. X-Ray
iv. Magnet, North Pole, South Pole

12. Ferrum Group: General Features
i. Ferrum
ii. Chromium
iii. Magnanum
iv. Cobalt
v Niccolum
vi. Cuprum
vii. Zincum
vii. Cadmium

13. Mercury Group: General Features
i. Mercury
ii. Syphilinum
iii. Aurum
iv. Palladium
v. Thallium
vi. Plumbum
vii. Stannum
viii.Gelsemium
ix. Sepia
x. Murex

Relationship of Remedies (Boenninghausen & Hering)

Concept of Related Totalities:
This has been stated in a most complete form by Boenninghausen in his Section on Relationship in the Therapeutic Pocket Book. The idea has been also developed by Hering, Clarke, Boger, Miller and many others. The concept relates similar pictures to each other, relates the main picture to splinter groups (Sector-wise or Miasm-wise), projects sequential changes likely to occur in the future under the influence of the selected remedy, relates the main picture to the partial expressions of Nosodes as anti-Miasmatic Drugs (Inter-currents) and also stresses antidotal as well as inimical relationships derived purely from clinical experience. Since this aspect of the Homoeopathic Materia Medica is found to be extremely useful in efficient Homoeopathic prescribing, training must provide a through grounding in this.
Acute, Chronic, Complementary, Antidotes, Remedies that Follow well, Inimicals, Sequences, Remedies that Precede well, Inter-currents, Nosodes, Constitutional Remedy and its spectrum of Acute Remedies.

1.Identification of these Categories with suitable Examples;
2. Programming of Treatment based on these Concepts;
3. Technique of employing the Section in Boenninghausen’s Therapeutic Pocket Book;
4. Follow-through of a Case on these lines;
Resolution of a mixed-up and complicated Case by adopting Vie Technique of Splitting of the Totality into homogenous components

Construction of Materia Medica:
Classified Symptoms when arranged with a certain philosophical background gives rise to different types of Materia Medica. Some Materia Medica sources keep the symptom of prover as narrated; others go on constructing Materia Medica from clinicopathological point of view, utilize the principle of generalization or emphasize the mental state & evolution of symptoms. Some are based on comparison of remedy action, remedy actions are presented in the commentary form or in the form of keynotes, some carry a mixture of clinical experience and proving depending upon the philosophy & experiences.Some keep the evolutionary as well as the disease angle in focus and attempt to relate the phenomena with the events in the life of the individual. This gives a richly documented data comprising of symptom-patterns to work upon and observe our remedies as live people interacting with their world whilst going about their business of living their lives. Such a unique mode of study (termed as Living Materia Medica) has a lot in store for us.

(5) Scope & Limitation of Materia Medica:
Scope and Limitations of different Materia Medicas as developed by the different authors listed below:
I. Hahnemann
2. T.F.Allen
3. J.T.Kent
4. Hering
5. Farrington
6. C. M.Boger
7. John Clarke
8. M. L. Dhawale
9. George Vithoulkas
ID. R. Shankaran
II. S. R. Phatak
12. Whitmont
13. Catherine Coulter

(ii) COMPARATIVE MATERIA MEDICA
From symptomatic, regional location, closely coming drug picture and group symptoms.

Comparisons: General Principles & Applications:
(a) Therapeutic Groupings with Reportorial Correlations and Differentiations
(b) Repertorial Syndromes: Concept and Differentiation
(c) Ailments from’ Rubrics from the Repertory:
Identification of the State Responsible and its Clinical Evaluation

Effects Produced: Evolution, Identification and Differentiation
Determination of the Prescribing Totality with the help of the Concomitants (Associated Symptoms and Characteristics of the Person).
In order to appreciate the application of the Materia medica at the bedside, it is necessary to appreciate the concept of acute totality as follows:

Concept of the Acute Totality:
Hahnemann regards acute diseases, which are not mere episodes as an explosion of Psora. From this follows the recommendation to give an anti-Psoric after the acute phase is over or to consider these whenever an acute disease runs an aberrant course. From this it would appear that the acute and chronic totalities have a certain definite relationship. These will be considered later on. We could consider Acute Totality under the following divisions:

(i) Acute General Totality: Portion of the Chronic Totality capable of expression in the acute phase .
(a) Causation and its Expression (Sensation and Complaints in General joined to Aggr & Amel)
(b) Mental State: Characteristic Expression with
(c) Fevers: Stages: Chill, Heat, Perspiration with Causation, Characteristic
Expression, and Compound Fevers:
(ii) Sector Totality: Local Regional affinities are considered here.
Chief Complaint(s): Locations
Pathology
Characteristic Expression: Cause
Sensations
&
Concomitants

Note:
1.Acute General Totality manifests itself much earlier in the pre-localization phase of the acute illness and although its expression varies within certain limits, it has a general consistency in its expression which permits us to identify the remedy not only in the early phases of the acute illness but also in the later stages, irrespective of the variations in the regional involvement(s).

2. Sector Totality varies as per involvement of the regions and takes time to evolve. In the later phases it may extend to involve other regions. With the advance of the disease, It tends to lose its specific characteristic expression while gaining in diagnostic expression. Differentiation. thus, becomes increasingly difficult with the advance of the disease.

3. Evolutionary aspects of both must be appreciated in depth as well as extent as at times these alone may furnish the guideline for prescribing.

4. Prescribing acute totality (ies) represents a combination of acute General as well as acute Sector totalities and thus present in actual practice a large number of pictures’ —all traceable to the same drug. This can be quite bewildering unless the above divisions are grasped.

6. If the drug under study is complete, it might have prescribing acute totalities corresponding to acute expressions related to the 4 Miasms. But these will be just splinters from the main block described under 4 above.

(iii) PRACTICE OF HOMOEOPATHY IN MEDICINE:

Detailed application of the knowledge of Materia Medica to different clinical condition from clinico-pathologico-miasmatic point of view. All general & systematic diseases keeping causation in view viz Infection, Immunological & Nutritional. The application aspect of knowledge of Organon & Philosophy along with repertory also needs to be integrated to attain the philosophical foundation of Homoeopathic practice and education. Here candidate will be tested on his knowledge of applied Materia Medica along with other basic concepts in Homoeopathic philosophy & practice

(iv) PRACTICE OF HOMOEOPATHY IN SURGERY AND OBS & GYN:
Application of Materia Medica its scope & limitation along with clinico pathologico-immunological-miasmatic? to different condition. Stress should be placed on surgery as a supportive system in case of emergency. Pre & Post operative homoeopathic care from Materia Medica point of view needs stress. The application aspect of knowledge of Organon & Philosophy along with repertory also needs to be integrated to attain the philosophical foundation of homoeopathic practice and education. Here candidate will be tested on his knowledge of applied Materia Medica along with other basic concepts in Homoeopathic philosophy & practice.

Homoeopathic Materia Medica: General acquaintance with the following categories of Books and the manner of employing them in the proper Study of Homoeopathic Materia Medica:

(i) Source Books
(a) Hahnemann: Materia Medica Pura
Chronic Diseases
(b) Hering:Guiding symptoms of the materia medica
(c) Allen: Encyclopaedia of Homoeopathic Materia Medica Handbook of Materia Medica
Nosodes
(d) Stephenson: Materia Medica & New Provings
(e) Hughes: Cyclopaedia of Drug Pathogenesey
(f) Anschutz: New Remedies

(ii) Compendium -
(a) Boericke: Materia Medics and Repertory
(b) Ghosh: Drugs of Hindustan

(iii) Commentaries
(a) Clarke: Dictionary of Homoeopathic Materia Medica
(b) Kent: Lectures on Homoeopathic Mate Medics and New Remedies
(c) Wheeler & Kenyon: Principles & Practice of Homoeopathy
(d) Pierce: Plain Talk on Homoeopathic Materia medica
(e) Farrington Harvey: Post-Graduate Course in Homoeopathy and Homoeopathic Prescribing
(f) Tyler, Margaret: Drug Pictures
(g) Royal: Materia Medica
(h) Boericke & Dewey: Twelve Tissue Remedies

Synopses
(a) Boger: Synoptic Key & Repertory to the Homoeopathic Materia Medica
(b) Pulford: Key to Homoeopathic Materia Medica
(c) Mathur : Systemic Materia Medica of Homoeopathic Remedies

(ii) Comparative Materia Medicas (Gross, Farrington and Roberts)
(iii) Repertories (See Practice of Homoeopathy)

(iv) Therapeutics
(a) Allen: Therapeutics of Fevers
(b) Tyler : Pointers to Remedies
(c) Nash: Typhoid
Respiratory Organs
(d) Hering & Wells : Typhoid
(e) Guernsey: Hemorrhoids
(f) Bell: Diarrhea
(g) Roberts: Rheumatic Remedies
(h) Pulford: Pneumonia
Influenza
Digestive Organs
Children’s Types
(i) Cartier: Respiratory Organs
(j) Royal: Diseases of Chest
Nervous Diseases
Practice of Medicine
(k) Yingling: Accoucher’s Manual
(I) Underwood: Headache

Note 1: The above is not an exhaustive List but a representative one. Detailed knowledge of these books or of the information contained in these is not expected of the candidate. But, he would be expected to be in a position to employ the book in a useful manner in the evolution of the Portrait of the Disease.

Note 2:
As per the CCH notification, the subject of Medica Medica must include the following:
1. Dynamics and methods of case taking.
2. Diagnosis and differential diagnosis of diseases with various physical, clinical and laboratory findings.
3. Analysis and synthesis of cases with Hahnemannian evolutional totality.
4. Selection of medicine including repertorisation and comparative study of Materia Medica.
5. Selection of Potency and dose.
6. Second prescription.
7. Remedy response and prognosis.
8. Management of the cases in general, therapeutic and accessory treatment in which case oriented method of study shall be adopted by integrating all disciplines.

COURSE OUTLINE

1. The course of study would be for a period of three years. Part I examination will be held at the end of one and half years and Part II after three years. The teaching of the specialty subject will begin from the first year itself.
2. There would be regular internal evaluation in the form of evaluation of written assignments, presentation at seminars and journal clubs and maintenance and processing of case records and clinical activities like acquisition of skills and ward work on the standard format.
3. The examination will be held after three years the details of which are appended below.
4. Guidelines for thesis are also appended separately

SCHEME OF EXAMINATION
A. Theory
A.1 Theory examination shall comprise 2 written papers; each of 100 marks (Total 200 marks). Passing shall be separate for theory.
A.2 Each paper will be divided in to two parts of 50 each and shall consist of two patterns of questions.
(a) SAQs (b) LAQs in the ratio 30:40 Each part will have
SAQ shall be 03 each of 5 mark = 15
SAQs shall be 03 each of 5 marks = 15
LAQs shall be 02 each of 10 marks = 20
......................................
Total Marks = 50
Time duration for each paper shall be 3 hours.
A.3. Three examiners (Out of which at least 2 are external) shall value the papers
A.4. ‘Passing’ shall be considered as score of 100 more marks out of total 200.
Passing shall be separate for theory.

Paper II
Section I:
1. Comparative Materia Medica;
2. Comparative study of symptoms, drug pictures and therapeutic indications of all drugs.

Section II
I. Practice of Homoeopathy in Medicine.
2. Practice of Homoeopathy in Surgery, Obstetrics and Gynecology.
B. Practical:
B. 1) 3 Examiners out of which 2 are External
B. 2) Clinical Long Case = I = 60 Marks (1 hr.)
Short Case = 1 = 40 Marks (1 hr.)

C. Viva Voce:
Amongst 3 examiners the marks shall be equally divided under four heads covering all the aspects of general & medicine as described in syllabus above. They can be broadly divided into four heads as below:

C.1 C.2 C.3 C.4

Basic Materia

Medica Group and Drug relationship Comparative Materia Medica

Practice of Homeopathic in Medicine
Surgery and Gynecology

(10 min) (10 min) (10 min) (10 min)

Marks max.
25 25 25 25

Viva & practical: 5O%marks is allotted for homoeopathic application
Total marks: Cases 100 Viva 100 = 200 marks
Separate passing in individual heads A, B & C is essential to pass in Examination.

INFORMATION